Micro-caps gone wild: the money-printing and the real wins
Audroc's 27x market-cap raise and Skyline's auditor exit lead a day of micro-cap theatre. Godrej Properties and NCC offer the mid-cap balance.
| Index | Level | Move |
|---|---|---|
| Bank Nifty | 58,291.50 | +0.61% |
| Nifty Auto | 27,353.95 | +1.36% |
| Nifty Energy | 39,481.45 | +0.77% |
| Nifty Financial Services | 29,422.60 | 0.00% |
| Nifty FMCG | 50,196.35 | +0.20% |
| Nifty Healthcare | 16,481.35 | 0.00% |
| Nifty IT | 27,276.45 | -0.59% |
| Nifty Media | 1,497.95 | -0.95% |
| Nifty Metal | 12,722.45 | +0.98% |
| Nifty Pharma | 25,866.25 | +0.47% |
| Nifty Private Bank | 16,648.10 | +2.00% |
| Nifty PSU Bank | 8,333.95 | -0.88% |
| Nifty Realty | 906.95 | +1.81% |
| Nifty Cement | 15,338.90 | 0.00% |
| Nifty Chemicals | 30,222.70 | 0.00% |
| Nifty Consumer Durables | 37,376.45 | 0.00% |
| Nifty Oil & Gas | 11,261.10 | 0.00% |
- Large-cap real estate (Godrej Properties) and construction (NCC) carried the broadest institutional relevance with land acquisition and order-book additions.
- Mid-cap IT (Cyient) signalled an AI-strategy pivot via acquisition, while railways (RVNL) showed a backward-looking profit miss offset by a large cash recovery.
- Micro-cap capital raises dominated the scoring, with Audroc, SK Minerals, and NHC Foods each proposing outsize dilution or deployment relative to market cap.
- Micro-cap governance and risk flags were sharp: Skyline Ventures auditor exit, HOCL indefinite plant shutdown, and Pulsar International losing its CFO.
- Small-cap engineering (Dee Development) and pharma (Wanbury) posted solid order wins and profit growth, offering a mid-tier operating counterpoint.
Audroc Ltd.
Audroc, a ₹3 crore trading company, wants to raise ₹80 crore — twenty-seven times its entire market value. If warrants convert, existing shareholders will own roughly 3% of the new equity base. The company pulled a smaller raise just weeks ago, making this second attempt the real story: what changed, and where does the money come from.
- 27x
- Proposed ₹80 crore raise relative
- ₹3.28 cr
- Micro cap mcap
- 17.94x
- P/E
- +315.97%
- PAT
- 2.74x
- D/E
Skyline Ventures India Ltd.
Skyline Ventures' auditor has quit in the middle of a forensic investigation into ₹10.45 crore of alleged fraud — a number that exceeds the company's ₹9 crore market cap. A forensic report has landed, and the company is in NCLT insolvency. For a nano-cap, losing the auditor during a probe is not a governance footnote; it is the governance story.
- ₹10.45 cr
- Alleged fraud under
- ₹8.73 cr
- Micro cap mcap
- -371.43%
- PAT
- 0.32x
- D/E
Godrej Properties Ltd.
Godrej Properties acquired a 23.2-acre plot in Greater Noida with ₹7,000 crore in estimated revenue potential — thirteen percent of its market cap and well above its entire FY26 consolidated revenue. This is not a land bank addition; it is a pipeline-defining bet. The scale of the development will test Godrej's execution bandwidth in a competitive NCR corridor.
- ₹7,000 cr
- Estimated revenue potential for
- ₹55,745 cr
- Large cap mcap
- 30.13x
- P/E
- +34.73%
- PAT
- +62.99%
- Rev
- 0.71x
- D/E
Alfa Transformers Ltd.
Alfa Transformers, a ₹40 crore company with declining revenue and 4.4% ROE, landed a ₹63 crore order for 12,000 transformers from a state utility. The contract is worth 157% of its market cap. For a business this small, execution on this single order determines whether the company remains relevant.
- ₹63 cr
- Order, or ~157% of Alfa's ₹40 cr
- ₹40.99 cr
- Micro cap mcap
- -813.04%
- PAT
- -23.37%
- Rev
- 0.41x
- D/E
NCC Ltd.
NCC secured ₹1,837 crore of orders in May alone, adding roughly 10% to annual standalone revenue in a single month. With an order book already at ₹83,004 crore, the new wins confirm sustained project flow across diversified segments. The pipeline visibility is real even if profit growth has been harder to come by.
- ₹1,837.01 cr
- Total new orders secured by NCC
- ₹9,643 cr
- Mid cap mcap
- 14.28x
- P/E
- -19.67%
- PAT
- +1.66%
- Rev
- 0.22x
- D/E
SK Minerals & Additives Ltd.
SK Minerals is raising ₹222 crore through convertible warrants, equal to 45% of its current market cap and potentially diluting existing shareholders by 49%. Promoters are taking over half the issue, signalling confidence, but the sheer scale relative to a ₹471 crore pesticide maker demands clarity on deployment. This follows a ₹424 crore market-cap disclosure just ten days ago that promised specifics without delivering them.
- ₹222 cr
- Capital to be raised from 60 lakh
- ₹461 cr
- Micro cap mcap
- 25.46x
- P/E
- 46.23%
- ROE
- 1.89x
- D/E
Cyient Ltd.
Cyient acquired TAO Digital, a Santa Clara-based AI and data engineering firm, for undisclosed terms. The deal slots directly into a strategy that already includes a ₹300 crore semiconductor fundraise and a push into GaN power chips. For a mid-cap IT firm with flat revenue growth, buying AI capability is the cheaper way to participate in a cycle it cannot afford to miss.
- Undisclosed
- Financial terms of the TAO
- ₹9,850 cr
- Mid cap mcap
- 23.02x
- P/E
- -64.74%
- PAT
- +0.93%
- Rev
- 0.03x
- D/E
NHC Foods Ltd.
NHC Foods, valued at ₹79 crore, is putting ₹202 crore into a new UK subsidiary with no stated operations. That is 2.5x its own market cap flowing into a shell company. The company's consolidated PAT did jump 74% on the back of an acquisition last year, but this deployment scale raises the same question: where is the money coming from, and what is the plan.
- ₹202 cr
- Investment into new UK
- ₹73.01 cr
- Micro cap mcap
- 6.16x
- P/E
- +641.81%
- PAT
- +92.07%
- Rev
- 0.38x
- D/E
LT Elevator Ltd.
LT Elevator landed its first three orders in Australia after clearing regulatory hurdles in a stringent market. For a ₹448 crore company with ₹111 crore in annual revenue, international expansion into developed markets is a genuine step-change, not a press-release gimmick. The company also plans to more than double its domestic touchpoints from 21 to 40, following a recent ₹50 crore fundraise from Bandhan and Motilal Oswal.
- ₹111 cr
- LT Elevator's annual revenue,
- ₹508 cr
- Micro cap mcap
- 29.83x
- P/E
- 9.88%
- ROE
- 0.38x
- D/E
Dee Development Engineers Ltd
Dee Development won a ₹206.55 crore piping order from a Maharatna PSU, representing over 22% of FY26 standalone revenue. The order adds to a book already grown 50% year-on-year. Yet the shadow of a second consecutive qualified audit on ₹47.62 crore of subsidiary assets with an expired PPA has not lifted, creating a tension between operating momentum and balance-sheet risk that management still has not addressed.
- ₹206.55 cr
- Value of a new Letter of Intent
- ₹4,622 cr
- Small cap mcap
- 59.75x
- P/E
- -12.17%
- PAT
- +26.26%
- Rev
- 0.51x
- D/E
Rail Vikas Nigam Ltd.
RVNL's Q4 profit dropped 43%, but the forward story is a ₹3,400 crore cash recovery from the Ministry of Railways in April. That inflow removes the single biggest balance-sheet overhang — the receivable dispute that auditors flagged across multiple filings — and backs management's 15-20% revenue growth guidance for FY27. The market has been pricing the profit decline; the recovery is the new variable.
- ₹3,400 cr
- Cash recovered from the Ministry
- ₹50,218 cr
- Large cap mcap
- 57.41x
- P/E
- -56.39%
- PAT
- +4.18%
- Rev
- 0.56x
- D/E
Supreme Infrastructure India Ltd.
SEBI has ordered acquirers of Supreme Infrastructure to launch a mandatory 26% open offer, a direct control event for a micro-cap with an ₹801 crore market cap. The acquirers are now challenging the regulator's directive. For a construction company trading at a 0.15x P/E with 314% revenue growth, the ownership question just became the stock.
- 26%
- Stake the acquirers are mandated
- ₹695 cr
- Micro cap mcap
- 0.13x
- P/E
- +86.4%
- PAT
- +314.44%
- Rev
- -0.46x
- D/E
Hindustan Organic Chemicals Ltd.
HOCL's Kochi phenol plant shutdown, initially disclosed as a 10-day maintenance event, is now indefinite with no restart date. For a ₹270 crore company dependent on a single manufacturing complex, an open-ended production halt is a direct hit to revenue and cash flow. The market was braced for a routine outage; it now faces an earnings gap it cannot size.
- Indefinite
- Duration of the extended phenol
- ₹255 cr
- Micro cap mcap
- -96.98%
- PAT
- -0.19%
- Rev
- 0.2x
- D/E
Natura Hue Chem Ltd.
A single off-market buyer picked up 10% of Natura Hue Chem, a dormant agricultural company with zero revenue, for ₹1.4 crore. The purchase triggers the Takeover Code and, given the company's state, almost certainly precedes some form of scheme or reverse-merger play. For a ₹14 crore shell with negative PAT growth, this is the filing that matters, not the balance sheet.
- ₹1.4 crore
- Value of the stake, about 10% of
- ₹14.63 cr
- Micro cap mcap
- -2033.33%
- PAT
- 0.02x
- D/E
-
In November 2025, Tolins management called the GST reduction on new tyres a 'large step'. By June 2026, those same tax changes are blamed for destroying retreading's price advantage, with EBITDA margins dropping from the guided ~20% to the new 10-13% range. The company that celebrated a policy shift is now petitioning the Ministry of Finance to reverse its impact.
TOLINS concall note -
Titagarh management said in November 2025 it was 'well on track' to deliver 100-120 passenger coaches. The actual number was 63, a miss of nearly 50%. Separately, management reversed its August 2025 denial that the Firema subsidiary was a cash drain, now citing 'continuous cash needs' as a reason for exit. Two material contradictions in one quarter.
TITAGARH concall note -
Rico Auto guided ₹80-90 crore in railway revenue across two prior calls. Actual FY24 railway revenue was ₹3-4 crore, because approvals were delayed. The EBITDA margin target of 12-13% was also missed at 7.1%, and has been quietly reset to 'above 10.25%'. Guidance credibility is now the central risk for a company with a ₹2,500 crore order book.
RICOAUTO concall note
-
Gufic Biosciences pulled its margin recovery timeline forward by two years, now guiding FY27 EBITDA at ~18% versus the FY29 target set in August 2025. The acceleration is driven by Indore CMO reaching break-even and a completed critical care working-capital reset. The Canadian dermal filler launch, however, slipped from June-July 2026 to Q3-Q4 FY27 with no explanation.
GUFICBIO concall note -
Kellton's CEO reversed his own risk playbook: in November 2025 he dismissed US market concerns, and in February 2026 he called AI disruption a 'market overreaction'. By June, both are cited as reasons for slower deal closures. Management guided FY27 revenue growth at 10%+ but conditioned it on geopolitical clarity within 60 days — a timeline it cannot control.
KELLTONTEC concall note -
Xelpmoc's portfolio company Mihup had a stated contracted ARR of ₹1 billion in November 2025. It is now $1 million, a drop of over 90% with no explanation offered. Management also withdrew a previously stated breakeven timeline of '1-2 quarters', refusing to provide any forward guidance. Two unexplained reversals in one quarter.
XELPMOC concall note
- India IIP (Industrial Production) · prev 4.15% YoY · impact M · a manufacturing read-through for the construction and engineering names in today's filings.
- India Non-Food Credit · prev 15.21% YoY · impact L · bank lending pace sets the tone for NBFC and infra funding flows.
- India Portfolio Net Equity Flows · prev -$6.47bn · impact M · foreign outflows remain the macro backdrop for mid- and small-cap liquidity.
- South Korea CPI · prev 2.57% YoY · impact H · a regional inflation signal that sets the tone for Asian central bank expectations.